Home
NewsNewsBirths resulting from essential Infertility Treatments, including advanced procedures like artificial insemination and IVF, have seen a very positive and promising climb, accounting for almost 15.1% of the total births recorded in 2024.
Two years ago, in 2024, one in seven newborns was born via infertility treatments like artificial insemination or in vitro fertilization – IVF as per a study in Korea. The proportion with regard to multiple births, including twins, has also seen a growth.
Confirms Study on Analysis of Side Effects of Infertility Treatments and Preparation of Management Plans from Health Insurance Review & Assessment Service, 36,025 out of 238,235 total births in 2024, which is about 15.1%, took place due to infertility treatments.
While the overall number of births saw a dip of 21.1% in a matter of five years, from 302,348 that were recorded in 2019 to 238,235 in 2024, rise in births with infertility treatments in Korea saw a jump of 36.6%, from 26,371 to 36,025. Notably, the proportion of births via infertility treatments almost doubled, rising from 8.7% to 15.1% between 2019 and 2024.
It is worth noting that the increase when it comes to infertility treatments has also gone on to raise the multiple birth rate. The size of multiple births across all the newborns grew from 4.6% in 2019 to 5.7% in 2024.
The rise in births with infertility treatments in Korea is due to the increasing age of marriage as well as childbirth, in addition to the health insurance coverage expansion when it comes to infertility treatments.
The proportion of multiple births in infants that were born by way of infertility treatments saw a slight dip from 35.5% in 2019 to 27.3% in 2024. But this does remain significantly higher as compared to the 1.6–1.8% rate for multiple births due to natural pregnancies. Apparently, the likelihood of multiple pregnancies increases when many embryos are transferred at the time of infertility treatment in order to enhance the success rates. The major dip when it comes to multiple births is attributed to the rising awareness of risks like maternal complications and also cerebral palsy in infants, thereby leading more parents to choose single-embryo transfers.
A professor of obstetrics and gynecology at the Seoul National University Hospital and also president of the Korean Maternal-Fetal Medicine Society, Park Jung-shin, said, “When undergoing infertility treatments, the various high-risk factors associated with multiple pregnancies must be thoroughly considered.”
The Stork Foundation for Infertility received a record 1,076 grant applications in 2026, with data revealing that 85% of applicants have no fertility treatment coverage for the care they are pursuing. Average anticipated next treatment costs stand at 19,149 USD, with 39% having already spent more than 10,000 USD out of pocket.
Future Health, A Global Initiative by Abu Dhabi has launched the Future Health Digital Health Innovation Challenge 2026, inviting global innovators to develop AI, software, and connected technology solutions across fertility, population health, and well-being. Three finalists will share USD 105,000 at GITEX 2026, with selected solutions eligible for incubation and scale.
La Trobe University and GonGlobal have entered a strategic collaboration to develop and validate AI and digital twin technologies for ART and IVF. The partnership will build AI-driven fertility care tools, including cohort matching digital twins and deep-learning models, to predict pregnancy outcomes and support personalised clinical decision-making.
IVI Institute has announced the acquisition of The World Egg and Sperm Bank (TWESB), founded in 2004 and operating from Scottsdale, Arizona. The move expands access to reproductive solutions for patients and clinics across the United States and Australia, combining TWESB’s network of 500+ screened donors with IVI Institute’s global clinical and scientific infrastructure.
Doctors at NHS Lothian in Edinburgh have performed the UK’s first testicular tissue transplant, reimplanting tissue frozen before chemotherapy in a 19-year-old patient with a serious blood disorder. The testicular tissue transplant, only the second reported worldwide, could eventually give thousands of young boys a realistic path to future fatherhood.
Flora Fertility and Clue have announced the Flora Clue fertility partnership, connecting the first individually owned fertility insurance platform with the world’s leading women-led cycle tracking app. FLORA policyholders receive complimentary Clue Plus access, while Clue’s community of over 100 million members gains early exposure to proactive fertility financial planning.
The World Health Organization releases its first comprehensive, evidence-based global guideline for infertility prevention, diagnosis, and treatment. Addressing one in six people of reproductive age worldwide, the guideline emphasizes equity, human rights, and standardized interventions to improve access to fertility care globally.
